Pfizer (PFE) has kicked off a Phase 2b study of vupanorsen (ANGPTL3) in statin-treated patients with elevated non-high-density lipoprotein cholesterol and triglycerides (TGs). …
Barclays analyst Jonathan Eckard is cautiously optimistic now that Ionis Pharmaceuticals (NASDAQ:IONS) has tested its pipeline drug nusinersen, a short stretch of nucleic …